Clinical Trial Update: Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating genomics-guided therapy selection in advanced urothelial carcinoma/bladder cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Urothelial Carcinoma, Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-11-06